Pricing

Protara Therapeutics Inc (TARA)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO: Jesse Shefferman
Employees: 30
Web site: protaratx.com
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
646-844-0337
Stock Split History
Date Ratio
2020-01-10 1:40
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Protara Therapeutics, Inc. engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the. treatment of lymphatic malformations. It also develops intravenous choline chloride, an. investigational phospholipid substrate replacement therapy.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available